Oligomerix receives NIH grant for Phase Ia Alzheimer’s disease study

Oligomerix receives NIH grant for Phase Ia Alzheimer’s disease study

Submitted by admin on August 10, 2022 - 10:45am
Source: 
Clinical Trials Arena
News Tags: 
Oligomerix
NIH
clinical trials
Alzheimer's disease
OLX-07010
Headline: 
Oligomerix receives NIH grant for Phase Ia Alzheimer’s disease study
snippet: 

The trial will analyze the safety, tolerability and pharmacokinetics of various doses of OLX-07010 in healthy elderly subjects.

Do Not Allow Advertisers to Use My Personal information